Open an account

TriMas

TRS · NASDAQ

$39.70+$0.27 (+0.68%)TodayMarket closed ·
Prev close $39.43

About TRS

TriMas Corp. engages in the manufacture of industrial products for customers in the consumer products, aerospace, industrial, petrochemical, refinery, and oil and gas end markets. The company is headquartered in Bloomfield Hills, Michigan and currently employs 3,700 full-time employees. The company went IPO on 2007-05-18. The firm's segments include Packaging and Specialty Products. Its Packaging segment offers dispensing, closure and flexible packaging solutions, including Rieke, Affaba & Ferrari, Taplast, Rapak and Aarts Packaging, along with Intertech and Omega Plastics, which provide life sciences–focused products. Its Packaging business develops and manufactures an array of dispensing products, polymeric and steel caps and closures, polymeric jar products, fully integrated dispensers for fill-ready bag-in-box applications, and consumable vascular delivery and diagnostic test components, all for a variety of consumer products submarkets. Its Specialty Products segment, which includes the Norris Cylinder business, designs, manufactures and distributes highly engineered steel cylinders.

Employees
3,700
Headquarters
Bloomfield Hills, Michigan
Listed
May 18, 2007
Sector
Materials
Industry
Containers & Packaging
Website
trimas.com

TRS key statistics

Market cap
1.42B
Price-earnings ratio
1.64
Dividend yield
0.45%
Average volume
279.45K
Volume
345.31K
Open price
$39.34
High today
$39.94
Low today
$38.86
52 Week high
$45.43
52 Week low
$30.43

TriMas (TRS) at a glance

TriMas (TRS) last traded at $39.70, with a market cap of 1.42B, a price-to-earnings ratio of 1.64 and a dividend yield of 0.45%.

Today the stock has traded between $38.86 and $39.94. The current price is 2.2% above the day's low and 0.6% below its high.

Volume so far is 345.31K shares, above the average of 279.45K shares a day.

Over the past year TriMas has ranged from $30.43 to $45.43, and now sits 62% of the way up that range.

TriMas met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.52 per share against an estimate of $0.4984.

The average analyst price target is $45.90, 15.6% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 3 analystsAvg $45.90
Low
$45.45
Now
$39.70
High
$47.25

TRS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 3329.4% on average.

  1. Q3 FY24: reported $0.43 per share against an estimate of $0.5338
  2. Q4 FY24: reported $0.43 per share against an estimate of $0.4803
  3. Q1 FY25: reported $0.46 per share against an estimate of $0.4045
  4. Q2 FY25: reported $0.61 per share against an estimate of $0.4858
  5. Q3 FY25: reported $0.61 per share against an estimate of $0.5691
  6. Q4 FY25: reported $0.40 per share against an estimate of $0.002
  7. Q1 FY26: reported $0.24 per share against an estimate of $0.1914
  8. Q2 FY26: reported $0.52 per share against an estimate of $0.4984

TRS news

  • Press releaseBusiness Wire

    TriMas Announces Third Quarter 2026 Earnings Conference Call Date

  • Press releaseBusiness Wire

    TriMas Packaging to Showcase Global Beauty Packaging Capabilities at Leading Trade Shows This Fall

  • Press releaseBusiness Wire

    TriMas Publishes 2025 Sustainability Report

  • Press releaseBusiness Wire

    TriMas Reports Second Quarter 2026 Results

  • Press releaseBusiness Wire

    TriMas Declares Quarterly Dividend

  • Press releaseBusiness Wire

    TriMas Announces Second Quarter 2026 Earnings Conference Call Date

  • Press releaseBusiness Wire

    TriMas Reports First Quarter 2026 Results

  • Press releaseBusiness Wire

    TriMas Declares Quarterly Dividend

Similar companies

Companies in the same industry as TriMas

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.